Articles tagged with 'Gibofsky' | Hospital for Special Surgery

Hospital for Special Surgery - Archive (Gibofsky)

2020
July
16,
2020
| 12:25 PM America/New_York
Healio Rheumatology featuring Allan Gibofsky, MD ...
Read more
2018
October
18,
2018
| 07:00 AM America/New_York
The Rheumatologist featured HSS rheumatologist Allan Gibofsky, MD, in an article about how to help patients with medication costs. "Not infrequently, patients will ask if a drug is covered by their formulary. When I make a drug decision, I may find ...
Read more
July
16,
2018
| 07:00 AM America/New_York
Healio Rheumatology featured HSS rheumatologist Allan Gibofsky, MD, in an article about access to biosimilars for patients. "It is a major concern that the potential benefits of biosimilar medications have not been trickling down to patients," said ...
Read more
June
25,
2018
| 07:00 AM America/New_York
Rheumatology Advisor interviewed HSS rheumatologist Allan Gibofsky, MD, about the potential financial benefits of switching stable patients with a rheumatic disease from an originator biologic to a biosimilar. "If a patient is stable on a biosimilar...
Read more
May
04,
2018
| 07:00 AM America/New_York
HSS rheumatologist Allan Gibofsky, MD, discussed how disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis (RA) affect a patient's vulnerability to infection for Rheumatology Advisor. "Many of the DMARDs and biologic agents used to...
Read more
April
06,
2018
| 07:00 AM America/New_York
Healio Rheumatology reported that the FDA rejected the approval of a biopharmaceutical company's biologics license applications. HSS rheumatologist Allan Gibofsky, MD, noted that this rejection demonstrates the careful scrutiny that the FDA applies ...
Read more
January
28,
2018
| 07:00 AM America/New_York
As biosimilar therapies for rheumatologic conditions are approved in the U.S., HSS rheumatologist Allan Gibofsky, MD discussed the perception and potential pricing of biosimilars in the print cover story of Healio Rheumatology. According to the arti...
Read more